FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+6.24%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$212M
AUM Growth
+$212M
(+8.5%)
Cap. Flow
+$11.6M
Cap. Flow
% of AUM
5.47%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
65
New
3
Increased
31
Reduced
4
Closed
4
Top Buys
| 1 |
LHCG
LHC Group LLC
LHCG
|
$5.03M |
| 2 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$5.02M |
| 3 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$4.21M |
| 4 |
AtriCure
ATRC
|
$1.66M |
| 5 |
Esperion Therapeutics
ESPR
|
$1.63M |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$4.27M |
| 2 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$3.97M |
| 3 |
LCI
Lannett Company, Inc.
LCI
|
$3.37M |
| 4 |
STAAR Surgical
STAA
|
$2.53M |
| 5 |
NeoGenomics
NEO
|
$1.21M |
Sector Composition
| 1 | Healthcare | 82.38% |
| 2 | Energy | 2.37% |
| 3 | Consumer Staples | 0.82% |
| 4 | Financials | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alkermes
ALKS
$4.95B
| $3.51M | 1.65% |
54,533
+4,936
| +10% | +$318K |
|
|
CPHD
27
DELISTED
Cepheid Inc
CPHD
| $3.34M | 1.57% |
54,691
+4,907
| +10% | +$300K |
|
28
HealthStream
HSTM
$831M
| $3.07M | 1.44% |
100,754
+9,064
| +10% | +$276K |
|
|
STRM
29
DELISTED
Streamline Health Solutions
STRM
| $3.05M | 1.43% |
72,495
+6,079
| +9% | +$255K |
|
30
Vertex Pharmaceuticals
VRTX
$102B
| $2.61M | 1.23% |
21,098
+1,733
| +9% | +$214K |
|
31
Standard BioTools
LAB
$493M
| $2.38M | 1.12% |
98,209
+8,717
| +10% | +$211K |
|
32
BioMarin Pharmaceuticals
BMRN
$11.3B
| $2.24M | 1.05% |
16,365
-8,241
| -33% | -$1.13M |
|
|
BLUE
33
DELISTED
bluebird bio
BLUE
| $1.96M | 0.92% |
896
-472
| -35% | -$1.03M |
|
|
STKL
34
SunOpta
STKL
$741M
| $1.74M | 0.82% |
161,690
+14,272
| +10% | +$153K |
|
35
Verastem
VSTM
$585M
| $1.72M | 0.81% |
19,045
+1,718
| +10% | +$155K |
|
|
36
Esperion Therapeutics
ESPR
$490M
| $1.63M | 0.77% |
+19,930
| New | +$1.63M |
|
37
Cytokinetics
CYTK
$5.98B
| $1.47M | 0.69% |
218,792
+19,778
| +10% | +$133K |
|
|
PETX
38
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.07M | 0.5% |
70,620
+6,414
| +10% | +$97K |
|
39
Humana
HUM
$37.5B
| $677K | 0.32% |
3,540
| – | – |
|
40
Elevance Health
ELV
$72.4B
| $672K | 0.32% |
4,095
| – | – |
|
|
AET
41
DELISTED
Aetna Inc
AET
| $665K | 0.31% |
5,215
| – | – |
|
42
United Therapeutics
UTHR
$17.7B
| $664K | 0.31% |
3,820
| – | – |
|
43
Viatris
VTRS
$12.3B
| $663K | 0.31% |
9,775
| – | – |
|
|
ENDP
44
DELISTED
Endo International plc
ENDP
| $650K | 0.31% |
8,161
| – | – |
|
|
AGN
45
DELISTED
Allergan plc
AGN
| $618K | 0.29% |
2,035
| – | – |
|
46
Novartis
NVS
$248B
| $597K | 0.28% |
6,774
| – | – |
|
47
Bristol-Myers Squibb
BMY
$96.7B
| $552K | 0.26% |
8,290
| – | – |
|
|
CELG
48
DELISTED
Celgene Corp
CELG
| $495K | 0.23% |
4,280
| – | – |
|
49
Becton Dickinson
BDX
$54.3B
| $481K | 0.23% |
3,480
| – | – |
|
50
Eli Lilly
LLY
$661B
| $459K | 0.22% |
5,495
| – | – |
|